Notable Analyst Rating Changes 07/01: (NFLX) (FOLD) (NBR) Upgraded; (GS) (MNKD) (URBN) Downgraded
Amicus Therapeutics (Nasdaq: FOLD) upgraded by two today:
- Leerink Swann from Market Perform to Outperform; and
- Janney Montgomery Scott from Neutral to Buy and moves its price target from $2.50 up to $5.
Raymond James moves Nabors (NYSE: NBR) from Market Perform to Outperform with a price target of $35.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
Bernstein drops Goldman Sachs